Codexis (CDXS) Short Interest Ratio & Short Volume → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free CDXS Stock Alerts $2.91 -0.14 (-4.59%) (As of 04:00 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Codexis Short Interest DataCurrent Short Volume2,370,000 sharesPrevious Short Volume2,380,000 sharesChange Vs. Previous Month-0.42%Dollar Volume Sold Short$6.38 millionShort Interest Ratio / Days to Cover4.2Last Record DateApril 15, 2024Outstanding Shares70,560,000 sharesPercentage of Shares Shorted3.36%Today's Trading Volume271,833 sharesAverage Trading Volume550,521 sharesToday's Volume Vs. Average49% Short Selling Codexis ? Sign up to receive the latest short interest report for Codexis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCDXS Short Interest Over TimeCDXS Days to Cover Over TimeCDXS Percentage of Float Shorted Over Time Ad Porter & CompanyTrump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. Codexis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,370,000 shares $6.38 million -0.4%N/A4.2 $2.69 3/31/20242,380,000 shares $8.31 million +3.9%N/A4 $3.49 3/15/20242,290,000 shares $7.63 million -9.8%N/A3.6 $3.33 2/29/20242,540,000 shares $11.81 million +0.8%N/A3.2 $4.65 2/15/20242,520,000 shares $8.16 million No ChangeN/A3.4 $3.24 1/31/20242,520,000 shares $6.63 million +1.6%N/A3.4 $2.63 Get the Latest News and Ratings for CDXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Codexis and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,480,000 shares $7.09 million -3.9%N/A3.2 $2.86 12/31/20232,580,000 shares $7.87 million -13.7%N/A3.2 $3.05 12/15/20232,990,000 shares $8.61 million +2.4%N/A3.5 $2.88 11/30/20232,920,000 shares $6.89 million -6.1%N/A3.6 $2.36 11/15/20233,110,000 shares $6.50 million +12.3%N/A3.7 $2.09 10/31/20232,770,000 shares $4.60 million +9.9%N/A2.9 $1.66 10/15/20232,520,000 shares $5.01 million +7.2%N/A2.5 $1.99 9/30/20232,350,000 shares $4.44 million -2.1%N/A2.1 $1.89 9/15/20232,400,000 shares $4.66 million +1.7%N/A2.2 $1.94 8/31/20232,360,000 shares $4.11 million -16.6%N/A2.4 $1.74 8/15/20232,830,000 shares $5.21 million +2.9%N/A2.5 $1.84 7/31/20232,750,000 shares $9.90 million -6.5%N/A2.6 $3.60 7/15/20232,940,000 shares $9.23 million -8.4%4.6%3.1 $3.14 6/30/20233,210,000 shares $8.99 million +2.2%5.0%3.5 $2.80 6/15/20233,140,000 shares $9.01 million -19.9%4.9%3.5 $2.87 5/31/20233,920,000 shares $8.66 million +1.0%6.1%4.7 $2.21 5/15/20233,880,000 shares $10.71 million -1.5%6.0%5.4 $2.76 4/30/20233,940,000 shares $15.44 million -9.4%6.1%6.4 $3.92 4/15/20234,350,000 shares $17.84 million -11.0%6.9%7.1 $4.10 3/31/20234,890,000 shares $20.24 million No Change7.7%7.8 $4.14 3/15/20234,890,000 shares $20.34 million -1.6%7.7%7.5 $4.16 2/28/20234,970,000 shares $24.03 million +4.2%7.8%7.4 $4.84 2/15/20234,770,000 shares $27.14 million -0.2%7.5%6.9 $5.69 1/31/20234,780,000 shares $29.40 million -5.7%7.5%5.9 $6.15 1/15/20235,070,000 shares $31.84 million -7.0%8.0%6.2 $6.28 12/30/20225,450,000 shares $25.40 million -0.7%8.6%6.4 $4.66 12/15/20225,490,000 shares $30.30 million +1.7%8.6%6.6 $5.52 11/30/20225,400,000 shares $29.54 million +7.8%8.5%6.6 $5.47 11/15/20225,010,000 shares $34.07 million -2.5%7.9%6.1 $6.80 10/31/20225,140,000 shares $28.89 million -3.6%8.1%7.1 $5.62 10/15/20225,330,000 shares $26.70 million +0.6%8.4%6.7 $5.01 9/30/20225,300,000 shares $32.12 million -3.6%8.4%5 $6.06 9/15/20225,500,000 shares $39.82 million No Change8.7%5.2 $7.24 8/31/20225,500,000 shares $38.56 million +1.9%8.7%5.1 $7.01READ THIS – If You Missed Out On The AI Boom (Ad)Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. CDXS Short Interest - Frequently Asked Questions What is Codexis' current short interest? Short interest is the volume of Codexis shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 2,370,000 shares of CDXS short. Learn More on Codexis' current short interest. What is a good short interest ratio for Codexis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CDXS shares currently have a short interest ratio of 4.0. Learn More on Codexis's short interest ratio. Is Codexis' short interest increasing or decreasing? Codexis saw a drop in short interest in April. As of April 15th, there was short interest totaling 2,370,000 shares, a drop of 0.4% from the previous total of 2,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Codexis' short interest compare to its competitors? Here is how the short interest of companies compare to Codexis: Century Therapeutics, Inc. (6.91%), Organigram Holdings Inc. (5.44%), X4 Pharmaceuticals, Inc. (7.30%), Design Therapeutics, Inc. (7.24%), Rigel Pharmaceuticals, Inc. (2.95%), Poseida Therapeutics, Inc. (6.55%), Zevra Therapeutics, Inc. (5.93%), Compass Therapeutics, Inc. (1.88%), Galectin Therapeutics Inc. (6.47%), Elevation Oncology, Inc. (13.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Codexis stock? Short selling CDXS is an investing strategy that aims to generate trading profit from Codexis as its price is falling. CDXS shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Codexis? A short squeeze for Codexis occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CDXS, which in turn drives the price of the stock up even further. How often is Codexis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDXS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Century Therapeutics Short Interest Organigram Short Interest X4 Pharmaceuticals Short Interest Design Therapeutics Short Interest Rigel Pharmaceuticals Short Interest Poseida Therapeutics Short Interest Zevra Therapeutics Short Interest Compass Therapeutics Short Interest Galectin Therapeutics Short Interest Elevation Oncology Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CDXS) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarProtect Your Bank Account Before It’s Too LateWeiss RatingsHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTruth about Trump you’ve never heardPorter & CompanyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group